RIPK2 anticorps (AA 1-540)

N° du produit ABIN7167474

Détail du produit anti-RIPK2 anticorps

Antigène: RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))

Épitope: AA 1-540

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RIPK2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Réactivité croisée: Humain, Rat

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Receptor-interacting serine/threonine-protein kinase 2 protein (1-540AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur RIPK2

Antigène: RIPK2 (Receptor-Interacting Serine-threonine Kinase 2 (RIPK2))

Autre désignation: RIPK2 (RIPK2 Produits)

Synonymes: anticorps RIPK2, anticorps 2210420D18Rik, anticorps CARD3, anticorps CARDIAK, anticorps CCK, anticorps D4Bwg0615e, anticorps RICK, anticorps RIP2, anticorps GIG30, anticorps receptor interacting serine/threonine kinase 2, anticorps receptor (TNFRSF)-interacting serine-threonine kinase 2, anticorps receptor-interacting serine-threonine kinase 2, anticorps RIPK2, anticorps Ripk2

Sujet:

Background: Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. Contributes to the tyrosine phosphorylation of the guanine exchange factor ARHGEF2 through Src tyrosine kinase leading to NF-kappaB activation by NOD2. Once recruited, RIPK2 autophosphorylates and undergoes \\\'Lys-63\\\'-linked polyubiquitination by E3 ubiquitin ligases XIAP, BIRC2 and BIRC3. The polyubiquitinated protein mediates the recruitment of MAP3K7/TAK1 to IKBKG/NEMO and induces \\\'Lys-63\\\'-linked polyubiquitination of IKBKG/NEMO and subsequent activation of IKBKB/IKKB. In turn, NF-kappa-B is released from NF-kappa-B inhibitors and translocates into the nucleus where it activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis. Plays also a role during engagement of the T-cell receptor (TCR) in promoting BCL10 phosphorylation and subsequent NF-kappa-B activation.

Aliases: CARD 3 antibody, CARD carrying kinase antibody, CARD containing ICE associated kinase antibody, CARD containing IL 1 beta ICE kinase antibody, CARD containing IL1 beta ICE kinase antibody, CARD containing interleukin 1 beta converting enzyme (ICE) associated kinase antibody, CARD containing interleukin 1 beta converting enzyme associated kinase antibody, CARD-containing IL-1 beta ICE-kinase antibody, CARD-containing interleukin-1 beta-converting enzyme-associated kinase antibody, CARD3 antibody, CARDIAK antibody, CCK antibody, CLARP kinase antibody, GIG 30 antibody, GIG30 antibody, Growth inhibiting gene 30 antibody, Receptor interacting protein (RIP) like interacting caspase like apoptosis regulatory protein (CLARP) kinase antibody, Receptor interacting protein 2 antibody, Receptor interacting serine threonine kinase 2 antibody, Receptor interacting serine/threonine protein kinase 2 antibody, Receptor-interacting protein 2 antibody, Receptor-interacting serine/threonine-protein kinase 2 antibody, RICK antibody, RIP 2 antibody, RIP like interacting CLARP kinase antibody, RIP-2 antibody, RIP-like-interacting CLARP kinase antibody, RIPK 2 antibody, Ripk2 antibody, RIPK2_HUMAN antibody, TNFRSF antibody, Tyrosine-protein kinase RIPK2 antibody, UNQ277/PRO314/PRO34092 antibody

UniProt: O43353

Pathways: TCR Signaling, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, Toll-Like Receptors Cascades